Peter Reynolds

The life and times of Peter Reynolds

Posts Tagged ‘UK CBD

CLEAR Withdraws Its Endorsement of UK CBD.

leave a comment »

uk cbd cannabinoid nutraceuticalsCLEAR can no longer endorse or recommend UK CBD as a supplier of CBD products.

This decision is made with regret but is unavoidable due to a number of problems which, despite our best efforts, have proved impossible to resolve.  Our endorsement was based on UK CBD’s ethical and quality standards but the position has changed and the directors of UK CBD have been unable satisfactorily to address our concerns.

Our main concern is that certain products marketed by UK CBD contain such high levels of the controlled drugs THC and CBN that we consider them to be unlawful.

One particular product, UK CBD 710 Cannabinoid Crystals, is being promoted as containing “over 4mg of THC”.  Anyone importing, supplying or in possession of this product risks criminal prosecution.

Potentially this product could destroy the whole CBD market.  If a prosecution was brought under the Psychoactive Substances Act 2016, it could result in all CBD products being regarded as psychoactive.

CLEAR strongly supports the developing CBD market as a legal alternative to high-THC products.  However, it is vital for the security of consumers that products comply with the law.

Written by Peter Reynolds

March 14, 2016 at 4:43 pm

CLEAR, The British Medicinal Cannabis Campaign and UK CBD Combine To Offer Media Briefings.

leave a comment »

coronation street landscape

The subject of cannabis as medicine is certain to rise to the top of the UK news agenda in forthcoming weeks as a new Coronation Street storyline unfolds.

The character Izzy Armstrong (Cherylee Houston) who has Ehlers-Danlos Syndrome, will be seen suffering when her prescription medicine fails to alleviate her pain. Erica Holroyd (Claire King) will then suggest that she starts using cannabis as an alternative and ends up supplying Izzy with the drug.  The programme will look at all aspects of the debate on medicinal cannabis and examine the legal implications and the far reaching consequences of Izzy’s actions for her family.

Now, three of the UK’s most important organisations in the field are joining forces to provide the media with facts, evidence and personal testimonies about medicinal cannabis.

CLEAR is the largest drugs policy reform group in the UK with nearly 600,000 followers. The British Medicinal Cannabis Campaign (BMCC) is an independent group consisting of 4,500 members, all of whom are UK-based medicinal cannabis users. UK CBD is the leading distributor of legal, cannabinoid nutraceuticals including the world famous Charlotte’s Web and Mary’s brands.

Roland Gyallay-Pap, managing director of CLEAR, commented:

Not for the first time, but at a crucial time in the worldwide debate, the issue of medicinal cannabis will be addressed in a British soap. We have high hopes that this will stimulate the debate and bring the absurdity of the UK government’s position into sharp focus.”

Throughout Europe, the USA, Canada, Australia, Israel and South America, interest in and the use of medicinal cannabis is growing fast. The UK is now virtually isolated amongst first world countries with the stubborn refusal of government even to consider the evidence. However there is a growing clamour from politicians, scientists and doctors that it must address what is a deeply cruel and evidence-free policy. Hundreds of thousands already use medicinal cannabis and risk a criminal record just for trying to improve their health. In addition they have to deal with a criminal underworld and risk violence, contaminated and low quality product all because government refuses to take responsibility.

There is now an overwhelming body of peer-reviewed, scientific evidence on the safety and efficacy of cannabis as medicine.  CLEAR published ‘Medicinal Cannabis: The Evidence’ in April 2015 which has received international acclaim and is now also available in a Spanish language edition.  Download here in English or Spanish.

Individual briefings will be available on request to journalists, reporters, media organisations and other interested parties. Briefings will be led by Peter Reynolds, one of the nation’s leading experts on the science, medicine and politics of cannabis, Mark Scott, a representative of BMCC and Nicolas Ellis, founder and managing director of UK CBD.

Please contact CLEAR to arrange a briefing at your premises by appointment.  Alternatively, a central London venue can be arranged on request.